Amyris (AMRS) News Today

SG Americas Securities LLC grew its holdings in Amyris, Inc. (NASDAQ:AMRS - Free Report) by 1,037.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 674,221 shares of the biotechnology company's stock after purchasi

Amyris, Inc. (NASDAQ:AMRS - Get Free Report) has been assigned an average recommendation of "Hold" from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and one has given a buy recommenda

Amyris, Inc. (NASDAQ:AMRS - Get Rating) was the recipient of a large growth in short interest during the month of May. As of May 31st, there was short interest totalling 65,520,000 shares, a growth of 14.0% from the May 15th total of 57,460,000 shares. Currently, 26.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 4,840,000 shares, the short-interest ratio is presently 13.5 days.

Amyris, Inc. (NASDAQ:AMRS - Get Rating) CFO Hermanus Kieftenbeld sold 20,999 shares of the firm's stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $0.95, for a total transaction of $19,949.05. Following the sale, the chief financial officer now owns 219,768 shares in the company, valued at approximately $208,779.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.